Tunable PEG-Azlactone Hydrogels Enable Programmable Multiphase Drug Delivery.
- DOI
- 10.1021/acs.biomac.6c00138
- Published
- 2026-05-13
- Container
- Biomacromolecules
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/acs.biomac.6c00138,
title = {Tunable PEG-Azlactone Hydrogels Enable Programmable Multiphase Drug Delivery.},
author = {Rasmussen E and Mohammad SKA and Kelly K and Bounds AG and Hulugalla K and Jankoski P and Stacy E and Jarrett WL and Clemons T and Smith AE and Werfel TA.},
year = {2026},
journal = {Biomacromolecules},
doi = {10.1021/acs.biomac.6c00138},
url = {https://doi.org/10.1021/acs.biomac.6c00138}
}RIS
TY - JOUR TI - Tunable PEG-Azlactone Hydrogels Enable Programmable Multiphase Drug Delivery. AU - Rasmussen E AU - Mohammad SKA AU - Kelly K AU - Bounds AG AU - Hulugalla K AU - Jankoski P AU - Stacy E AU - Jarrett WL AU - Clemons T AU - Smith AE AU - Werfel TA. PY - 2026 JO - Biomacromolecules DO - 10.1021/acs.biomac.6c00138 UR - https://doi.org/10.1021/acs.biomac.6c00138 ER -
APA
E, R., SKA, M., K, K., AG, B., K, H., P, J., E, S., WL, J., T, C., AE, S., & TA., W. (2026). Tunable PEG-Azlactone Hydrogels Enable Programmable Multiphase Drug Delivery.. Biomacromolecules. https://doi.org/10.1021/acs.biomac.6c00138
Source records
- europe-pmc · retrieved 2026-09-25T21:04:59.183Z